Mexico has approved bio-pharmaceutical major Biocon's insulin Glargine. Mexican health authority COFEPRIS,, through its partner PiSA Farmaceutica (PiSA), approved the insulin, it was announced on Friday (10 April). Mexico has been a very important market for Biocon since 2006, where it has been playing a significant role in enabling access to affordable rh-Insulin. Insulin Glargine will augment the affordable insulins therapy for diabetes management. ‘GALACTUS’ by PiSA is the first Insulin Glargine to be approved in Mexico as per the biocomparable approvals pathway defined in 2012. Biocon is as Asia’s largest insulins producer and has been committed to affordable diabetes management through rh-Insulin (Insugen ®) and Insulin Glargine (Basalog ®) in India and several emerging markets. The company currently has marketing approvals in over 60 countries for rh-Insulin and in over 20 countries for Insulin Glargine. Biocon Chairperson & Managing Director Kiran Mazumdar-Shaw said: “We are committed to make global impact with our affordable insulins therapy. Our Insulin Glargine, will now enable access to a basal insulin which will further expand the diabetes management therapy for patients in Mexico.” Diabetes is a major health risk in Mexico, over 70 per cent of the Mexican population is overweight thus prone to developing diabetes. With over 9 million cases of diabetes, it poses a huge disease burden for the government with per capita expenditure on diabetes being as high as $892.5. Biocon’s presence in Mexico, over the last eight years, has expanded the insulins market substantially by initiating many more patients onto insulin therapy. The increasing affordability of Insulin Glargine will now enable Biocon and PiSA to expand this reach further. The combined market for Insulin Glargine in Mexico is estimated to be in excess of $40 million.
Read More
Norbert Hueltenschmidt, head, Healthcare Practice, Europe, Middle East and Africa, Bain & Company, tells BW’s Joe C. Mathew what the the government’s healthcare priorities should be.
Read More
A new India has to be built on the foundation of a healthy India. Countries around the globe have kept healthcare at the core of their economic development. The socio-economic benefit of a strong healthcare sector not only translates into the creation of a healthy and more productive community but is also one of the world’s largest and fastest growing sectors.
Read More
On 1 November, Kerala kick-started a scheme to distribute generic drugs free to all patients in five government medical college hospitals and three general hospitals in Thiruvananthapuram, Kochi and Kozhikode. A total of 952 drugs, including antibiotics and those for cancer, respiratory, cardiac, ophthalmic and ENT ailments, will be procured and supplied by the Kerala Medical Services Corporation (KMSCL) to these hospitals.
Read More
As per the study published in journal Scientific Reports, a new organ of human body has been discovered which is termed as “Interstitium”. According to the study, it may be one of the largest organs of the human body. Researchers have found a network of fluid cells completely surrounded by the connective tissues which fills the space between human body organs. Let’s know more about the Interstitium:
Read More
Eating lots of sugar over time can cause you to gain weight and scientific evidence shows that being overweight increases the risk of 13 different types of cancer, most importantly - breast, colon, womb, kidney, pancreas & esophagus, says Kabir Rehmani, Senior Consultant, Surgical Oncology, Fortis Hospital, Noida. Read on to find out the indirect link between cancer risk and sugar
Read More
World diabetes day was first observed on 14th November 1991 by the initiative of world health organisation and International diabetes federation. This day was created in response to growing health threat in the world by diabetes. More than 160 countries in the world campaign for the awareness of diabetes which affect more than 1 billion people. The theme of World Diabetes Day 2017 is Women and Diabetes. What is Diabetes? When the Pancreas stop making Insulin or body cannot use the Insulin produced by the pancreas it results in the Diabetes. Insulin acts as a catalyst when the human body converts glucose into energy. Insulin helps glucose to be consumed by the cells. There are three types of Diabetes - Type 1 Diabetes, Type 2 Diabetes and GDM (Gestational diabetes). A Diabetic patient must have these things handy to fight this chronic disease:
Read More
There is no doubt that regular exercise is good for our physical health and longevity. Exercise is also beneficial for our mental health and cognitive function. The research that was published in the journal Neurology showed that regular exercise may help slow or prevent brain shrinkage in people in the very early stages of the Alzheimer’s disease.Many other studies show that physical activity helps to boost overall brain power, and increase productivity and mood. If you dread workout, hopefully, you will change your mind after you read the following reasons exercise is good for your brain:
Read More
